IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION

Area of Science:

• Immunology
• Pharmacology

Background:

• Allograft survival is critical in organ transplantation.
• Immunosuppressive drugs like Cyclosporine (CsA) are essential but have limitations.
• Novel immunosuppressants are needed to improve outcomes.

Purpose of the Study:

• To compare the in vitro immunosuppressive potency of FR 900506 (FR) and Cyclosporine (CsA).
• To evaluate the efficacy of FR in inhibiting human lymphocyte proliferation.
• To assess FR's potential as an immunosuppressive agent in organ transplantation.

Main Methods:

• In vitro assessment of lymphocyte proliferation.
• Concanavalin A (ConA) stimulation assays.
• Primary and secondary mixed lymphocyte reactions (MLR).
• Analysis of alloactivated T cells from MLR and liver transplant biopsies.

Main Results:

• FR 900506 demonstrated significantly greater inhibition of lymphocyte proliferation compared to CsA at lower doses.
• FR was approximately 500-fold more potent than CsA in vitro.
• Similar potency differences were observed in both primary and secondary immune responses.

Conclusions:

• FR 900506 exhibits superior in vitro immunosuppressive activity compared to CsA.
• The potent efficacy of FR suggests its potential as a valuable agent for improving allograft survival in organ transplantation.